ALESSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alesse, and when can generic versions of Alesse launch?
Alesse is a drug marketed by Cadence Health and is included in one NDA.
The generic ingredient in ALESSE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for ALESSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALESSE at DailyMed |
Recent Clinical Trials for ALESSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
Université de Montréal | Phase 2 |
National Institutes of Health (NIH) | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ALESSE
US Patents and Regulatory Information for ALESSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 020683-001 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cadence Health | ALESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 020683-002 | Mar 27, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |